Bliden, Kevin P.
Raviv, Gabe
Tantry, Udaya S.
Chaudhary, Rahul
Cochran, John W.
Navarese, Eliano P.
Brannan, Tricia
Vyas, Ankit
Gurbel, Paul A.
Article History
First Online: 23 January 2019
Compliance with ethical standards
:
: Dr Gurbel reports serving as a consultant or receiving honoraria for lectures, consultations, including service on speakers’ bureaus from Bayer, Merck, Janssen, Medicure, and World Medical; receiving grants from the National Institutes of Health, Janssen, Bayer, Haemonetics, Instrumentation Labs, Coramed Technologies, LLC and Amgen. Dr. Gurbel is holding stock or stock options in Merck, Medtronic, and Pfizer; and holding patents in the area of personalized antiplatelet therapy and interventional cardiology. Dr. Cochran serves on speakers bureau and does consulting for Merck, Avanir and Amgen. Dr. Raviv reports serving as a consultant for Haemonetics. Other authors report no disclosures.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional ethical committee and with the 1964 Helsinki declaration and its later amendments.
: Informed consent was obtained from all individual participants included in the study.